Suppr超能文献

四十年的重复筛查:原位癌的意义

Forty years of repeated screening: the significance of carcinoma in situ.

作者信息

Morrison B J, Coldman A J, Boyes D A, Anderson G H

机构信息

Department of Health Care and Epidemiology, University of British Columbia, Vancouver, Canada.

出版信息

Br J Cancer. 1996 Sep;74(5):814-9. doi: 10.1038/bjc.1996.441.

Abstract

Two cohorts of women born in 1914-18 and 1929-33 who participated in a cervical screening programme have been followed for over 40 years. Age-specific incidence rates of squamous carcinoma of the cervix by rank of smear and length of interval between smears are reported. The younger cohort, who had undergone more frequent screening, had lower rates of invasive disease. From these incidence rates, estimates of false-negative rates and regression rates for carcinoma in situ have been made. The false-negative rate was estimated to be about 15%. Regression seemed more frequent in younger than in older women. For the younger cohort it was estimated to be 72% and in the older 47%. A comparison of the rates of in situ carcinoma with those of invasive disease suggests that the screening of the younger cohort reduced the rate of invasive disease to at least one-half or one-third of what it would have been if screening had commenced later. Rates of disease appear less dependent on age than previously thought and are consistent with causation by an infective agent.

摘要

两组分别出生于1914 - 1918年和1929 - 1933年且参与了宫颈筛查项目的女性已被跟踪随访40多年。报告了按涂片等级和涂片间隔时间划分的宫颈鳞状细胞癌的年龄别发病率。较年轻的那组女性接受筛查的频率更高,其浸润性疾病的发病率较低。根据这些发病率,对原位癌的假阴性率和消退率进行了估计。假阴性率估计约为15%。消退现象在年轻女性中似乎比在年长女性中更常见。对于较年轻的那组女性,估计为72%,而在年长女性中为47%。原位癌发病率与浸润性疾病发病率的比较表明,对较年轻组女性的筛查将浸润性疾病的发病率降低至如果筛查开始得更晚时发病率的至少二分之一或三分之一。疾病发病率似乎不像之前认为的那样依赖年龄,并且与感染因子导致发病的情况相符。

相似文献

1
Forty years of repeated screening: the significance of carcinoma in situ.
Br J Cancer. 1996 Sep;74(5):814-9. doi: 10.1038/bjc.1996.441.
2
The value of a Pap smear program and suggestions for its implementation.
Cancer. 1981 Jul 15;48(2 Suppl):613-21. doi: 10.1002/1097-0142(19810715)48:1+<613::aid-cncr2820481328>3.0.co;2-z.
3
A longitudinal Swedish study on screening for squamous cell carcinoma and adenocarcinoma: evidence of effectiveness and overtreatment.
Cancer Epidemiol Biomarkers Prev. 2007 Dec;16(12):2641-8. doi: 10.1158/1055-9965.EPI-07-0278.
4
Organisation and results of the cervical cytology screening programme in British Columbia, 1955-85.
Br Med J (Clin Res Ed). 1988 Apr 2;296(6627):975-8. doi: 10.1136/bmj.296.6627.975.
6
Effect of regular 3-yearly screening on the incidence of cervical smears: the Leiden experience.
Cytopathology. 1990;1(4):201-10. doi: 10.1111/j.1365-2303.1990.tb00348.x.
8
Mass screening programmes and trends in cervical cancer in Finland and the Netherlands.
Int J Cancer. 2008 Apr 15;122(8):1854-8. doi: 10.1002/ijc.23276.
9
Trends in cancer of the cervix uteri in Sweden following cytological screening.
Br J Cancer. 1999 Sep;81(1):159-66. doi: 10.1038/sj.bjc.6690666.

引用本文的文献

1
Are CIN3 risk or CIN3+ risk measures reliable surrogates for invasive cervical cancer risk?
J Am Soc Cytopathol. 2020 Nov-Dec;9(6):602-606. doi: 10.1016/j.jasc.2020.07.133. Epub 2020 Jul 29.
2
Follow-Up of Women with Cervical Cytological Abnormalities: Progression and Regression Events.
Asian Pac J Cancer Prev. 2019 Apr 29;20(4):1019-1024. doi: 10.31557/APJCP.2019.20.4.1019.
3
Impact of Age at Conization on Obstetrical Outcome: A Case-Control Study.
J Low Genit Tract Dis. 2017 Apr;21(2):97-101. doi: 10.1097/LGT.0000000000000293.
4
Disease detection and resource use in the safety and control arms of the HPV FOCAL cervical cancer screening trial.
Br J Cancer. 2016 Dec 6;115(12):1487-1494. doi: 10.1038/bjc.2016.368. Epub 2016 Nov 17.
5
Clinical application of DNA ploidy to cervical cancer screening: A review.
World J Clin Oncol. 2014 Dec 10;5(5):931-65. doi: 10.5306/wjco.v5.i5.931.
6
Point: cervical cancer screening guidelines should consider observational data on screening efficacy in older women.
Am J Epidemiol. 2013 Oct 1;178(7):1020-2. doi: 10.1093/aje/kwt167. Epub 2013 Aug 21.

本文引用的文献

1
Experience with cervical screening in British Columbia.
Gynecol Oncol. 1981 Oct;12(2 Pt 2):S143-55. doi: 10.1016/0090-8258(81)90070-6.
3
"Pap" smear and the risk of cervical neoplasia: quantitative estimates from a case-control study.
Lancet. 1984 Oct 6;2(8406):779-82. doi: 10.1016/s0140-6736(84)90705-0.
4
Cervical cancer detection in British Columbia. A progress report.
J Obstet Gynaecol Br Commonw. 1968 Apr;75(4):392-404. doi: 10.1111/j.1471-0528.1968.tb00136.x.
5
Cancer of the cervix: a sexually transmitted infection?
Lancet. 1974 May 25;1(7865):1037-40. doi: 10.1016/s0140-6736(74)90432-2.
6
A case-control study of cervical cancer screening in north east Scotland.
Br Med J (Clin Res Ed). 1985 May 25;290(6481):1543-6. doi: 10.1136/bmj.290.6481.1543.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验